Indication
von Hippel-Lindau syndrome
2 clinical trials
2 products
Clinical trial
An Open Label Phase 2 Study to Evaluate PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell CarcinomaStatus: Completed, Estimated PCD: 2023-08-30
Product
PT2385Clinical trial
An Open-Label Phase 2 Study to Evaluate PT2977 for the Treatment of Von Hippel Lindau Disease-Associated Renal Cell CarcinomaStatus: Active (not recruiting), Estimated PCD: 2026-03-29
Product
Belzutifan